Ivan John Clement
ABOUT
Ivan is a scientist at Eli Lilly and Company where he builds systems pharmacology models to find the right dose to produce the right action inside the right patient.
Stories by Ivan John Clement
Making Pricey Pills Cheaper
Developing new drugs is undeniably expensive. Could big data and innovating funding mechanisms work together to make them more accessible to those who need it most?
Making Pricey Pills Cheaper
Developing new drugs is undeniably expensive. Could big data and innovating funding mechanisms work together to make them more accessible to those who need it most?

